921592-85-0

Upstream product

• 4548-45-2 2-chloro-5-nitropyridine 
• 40499-83-0 (3R)-pyrrolidinol 
• 5418-51-9 5-nitro-2-hydroxypyridine 

Downstream Products

• 1010398-48-7 2-[(3S)-3-(2-fluorophenoxy)pyrrolidin-1-yl]-5-nitropyridine 
• 921592-86-1 (R)-1-(5-aminopyridin-2-yl)pyrrolidin-3-ol 
• 1419600-68-2 (R)-1-((1-(3-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)-3-(6-(3-hydroxypyrrolidin-1-yl)pyridin-3-yl)urea 
• 1419604-07-1 (R)-phenyl 6-(3-hydroxypyrrolidin-1-yl)pyridin-3-ylcarbamate 

Relevant academic research and scientific papers

SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands

Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands, pharmaceutical compositions containing these compounds and also to a method of using these compounds for treating and/or inhibiting pain and further diseases and/or disorders.

STEAROYL COA DESATURASE INHIBITORS

The present invention relates to novel Stearoyl CoA desaturase (SCD) inhibitors and uses thereof for treating diseases, conditions and/or disorders modulated by a Stearoyl CoA desaturase enzyme. The SCD inihibitors have the formula (I) or a pharmaceutical

THERAPEUTIC AGENTS

Compounds of formula (I), processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.